ESSA Pharma Inc. (EPIX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch EPIX
See up to 3 months of EPIX. The 7-day demo opens the 1M and 3M ranges and puts EPIX on your watchlist.
Start 7-day demoLatest EPIX insider trades
About ESSA Pharma Inc. (EPIX)
ESSA Pharma Inc. files with the SEC under CIK 0001633932 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
EPIX Form 4 activity by transaction type, last 90 days
No Form 4 activity for EPIX in the last 90 days.
EPIX insider transactions (Form 4)
2411 Form 4 filings on record, the earliest from Oct 7, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David S. Wood - Officer | Derivative | Common Shares | 33,343 | - footnote F1 | - | |
| ||||||
| Scott Requadt - Director | Derivative | Common Shares | 30,002 | - footnote F1 | - | |
| ||||||
 Marella Thorell - Director | Derivative | Common Shares | 2,881 | - footnote F1 | - | |
| ||||||
| John Alexander Martin - Director | Derivative | Common Shares | 14,299 | - footnote F1 | - | |
| ||||||
| David Ross Parkinson - Officer | Derivative | Common Shares | 65,675 | - footnote F1 | - | |
| ||||||
| Richard M. Glickman - Director | Derivative | Common Shares | 43,240 | - footnote F1 | - | |
| ||||||
| Franklin M. Berger - Director | Derivative | Common Shares | 784,404 | - footnote F1 | - | |
| ||||||
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 6,194,145 | - footnote F6 | - | |
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 4,726,743 | - footnote F6 | - | |
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 560,797 | - footnote F6 | - | |
| ||||||
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 1,481,634 | $0.00 | $148 | |
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 1,235,030 | $0.00 | $124 | |
| BVF PARTNERS L P - 10% Owner | Other | Common Stock | 203,336 | $0.00 | $20 | |
| BVF PARTNERS L P - 10% Owner | Open-market sale | Common Stock | 79 | $1.88 | $148 | |
| BVF PARTNERS L P - 10% Owner | Open-market sale | Common Stock | 66 | $1.88 | $124 | |
| BVF PARTNERS L P - 10% Owner | Open-market sale | Common Stock | 11 | $1.88 | $21 | |
| BVF PARTNERS L P - 10% Owner | Other | Pre-funded Warrants | 1,481,634 | $0.00 | - | |
| BVF PARTNERS L P - 10% Owner | Other | Pre-funded Warrants | 1,235,030 | $0.00 | - | |
| BVF PARTNERS L P - 10% Owner | Other | Pre-funded Warrants | 203,336 | $0.00 | - | |
| Growth N. V. Biotech | Open-market sale | Common Shares | 2,000,000 | $1.53 | $3.06M | |
| Growth N. V. Biotech | Open-market sale | Common Shares | 2,000,000 | $1.53 | $3.05M | |
| Growth N. V. Biotech | Open-market sale | Common Shares | 2,000,000 | $1.53 | $3.06M | |
| Growth N. V. Biotech | Open-market sale | Common Shares | 1,879,583 | $1.51 | $2.84M | |
| Peter Virsik - Officer | Open-market sale | Common Shares | 694 | $6.03 | $4K | |
EPIX insider trading FAQ
What is the latest insider trade for EPIX?
ESSA Pharma Inc. (EPIX) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-10-09. The full record for EPIX runs to 11 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EPIX stock?
No insider purchases of EPIX were filed in the last 90 days.
How many insiders are selling EPIX stock?
No insider sales of EPIX were filed in the last 90 days. 8 sales are on record for this company.
Where can I see EPIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EPIX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David S. Wood view on EDGAR
- - Scott Requadt view on EDGAR
- - Marella Thorell view on EDGAR
- - John Alexander Martin view on EDGAR
- - David Ross Parkinson view on EDGAR
- - Richard M. Glickman view on EDGAR
- - Franklin M. Berger view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Growth N. V. Biotech view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where EPIX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EPIX with a 7-day demo
- EPIX on your watchlist
- Every EPIX Form 4 filing on record
- Up to 3 months of EPIX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
